Stay updated on Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T18:55:11.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error page content for this study. The page now loads the standard study details layout, indicating access to the study information.
    Difference
    0.5%
    Check dated 2026-09-29T19:23:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record content. As a result, the usual study details, related links, and navigation are not accessible.
    Difference
    18%
    Check dated 2026-09-22T22:37:51.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0, signaling a new version of the page template. This change reflects a metadata version update rather than a substantive modification to the study details.
    Difference
    0.0%
    Check dated 2026-09-15T22:15:40.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Latest revision entries (Aug 2026) were added to the page's history, including 2026-08-26, 2026-08-24, and 2026-08 with Revision: v3.6.6. An older revision entry (Revision: v3.6.5) was removed from the history.
    Difference
    0.2%
    Check dated 2026-09-01T19:44:34.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Two new NIH grant/contract entries (2019 and 2023) were added to the study's identifiers, updating the funding references associated with the trial.
    Difference
    0.1%
    Check dated 2026-08-25T21:30:15.000Z thumbnail image

Stay in the know with updates to Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable Fulvestrant in Breast Cancer Clinical Trial page.